PETRIOLI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 3.043
EU - Europa 2.357
AS - Asia 380
SA - Sud America 10
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.796
Nazione #
US - Stati Uniti d'America 3.037
GB - Regno Unito 675
IE - Irlanda 561
CN - Cina 308
SE - Svezia 253
IT - Italia 217
UA - Ucraina 213
FR - Francia 117
BE - Belgio 98
DE - Germania 95
FI - Finlandia 63
ES - Italia 41
VN - Vietnam 29
IN - India 22
CL - Cile 9
IR - Iran 9
CA - Canada 6
AU - Australia 5
TR - Turchia 5
NL - Olanda 4
RU - Federazione Russa 4
BD - Bangladesh 3
BG - Bulgaria 3
RO - Romania 3
DK - Danimarca 2
HU - Ungheria 2
KZ - Kazakistan 2
CH - Svizzera 1
EU - Europa 1
GR - Grecia 1
IQ - Iraq 1
JP - Giappone 1
LU - Lussemburgo 1
PL - Polonia 1
RS - Serbia 1
SI - Slovenia 1
VE - Venezuela 1
Totale 5.796
Città #
Southend 630
Dublin 556
Fairfield 538
Ashburn 269
Woodbridge 251
Chandler 230
Ann Arbor 211
Wilmington 198
Cambridge 188
Seattle 184
Jacksonville 179
Houston 168
Brussels 98
Princeton 91
Siena 66
New York 65
Beijing 59
Nanjing 56
Shanghai 46
San Mateo 39
Málaga 37
Helsinki 32
Boardman 29
Dong Ket 29
San Diego 26
Shenyang 22
Nanchang 18
Jiaxing 15
Hebei 10
London 10
Venezia 10
Rome 9
Zhengzhou 9
Arezzo 8
Kunming 8
San Francisco 8
Santiago 8
Florence 7
Tianjin 7
Dearborn 6
Fremont 6
Norwalk 6
Redwood City 6
Zanjan 6
Changsha 5
Düsseldorf 5
Milan 5
Ningbo 5
Taizhou 5
Tappahannock 5
Viareggio 5
Vijayawada 5
Aosta 4
Guangzhou 4
Hangzhou 4
Leawood 4
Bangalore 3
Islington 3
Jinan 3
Narni 3
New Bedfont 3
Sacramento 3
Santa Maria Capua Vetere 3
Washington 3
Winnipeg 3
Alessandria 2
Amsterdam 2
Andover 2
Bathinda 2
Canberra 2
Dresden 2
Groningen 2
Gunzenhausen 2
Haikou 2
Hefei 2
Hyderabad 2
Izmir 2
Kiskunfelegyhaza 2
Lanzhou 2
Los Angeles 2
Madrid 2
Marseille 2
Mestre 2
Montemurlo 2
Montespertoli 2
Monza 2
Pisa 2
San Giuliano Milanese 2
Serra 2
Teano 2
Toronto 2
Trieste 2
Verona 2
Acton 1
Adliswil 1
Albignasego 1
Alessano 1
Almaty 1
Baghdad 1
Belgrade 1
Totale 4.600
Nome #
Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy 211
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer 189
C-Met targeting in advanced gastric cancer: An open challenge 183
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 175
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer 171
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer 165
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer 162
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study 148
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer 147
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience 146
CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab 142
Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results 137
28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis 136
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 133
Gastric cancer: Current status of lymph node dissection 131
Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status 129
Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients 126
Analysis of biochemical bone markers as prognostic factors for survival in patients with hormone-resistant prostate cancer and bone metastases 122
Short-term and long-term risk factors in gastric cancer 115
null 112
null 112
Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials 110
null 110
null 109
Hyperprogressive disease in advanced cancer patients treated with nivolumab: a case series study 104
null 103
null 98
null 98
A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer 98
null 96
null 96
Treatment of bone metastases with dichloromethylene bisphosphonate 94
GEMCITABINE (dFdC), 5-FLUROURACIL (5FU), AND FOLINIC ACID (FA) IN THE TREATMENT OF PATIENTS WITH GASTRO-ENTERIC CARCINOMAS: A CLINICAL AND PHARMACOLOGICAL STUDY. 91
null 89
null 88
null 87
Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer 87
Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer 87
A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient 85
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study: TILs for ADJ-untreated stage II colon cancer 80
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: A meta-analysis of four randomized trials 78
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer 76
Signet ring cell percentage in poorly cohesive gastric cancer patients: A potential novel predictor of survival 70
Preoperative or perioperative docetaxel, oxaliplatin, and capecitabine (GASTRODOC regimen) in patients with locally-advanced resectable gastric cancer: A randomized phase-II trial 61
Squamous cell carcinoma of the maxillary sinus: A retrospective analysis of 36 cases 57
Association of Concomitant Bone Resorption Inhibitors with Overall Survival among Patients with Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate with Prednisone as First-Line Therapy 49
A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report 48
Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence 48
Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis 46
Clinical value and impact on prognosis of peri-operative CA 19-9 serum levels in stage I and II adenocarcinoma of the pancreas 45
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer 45
Five years of stable disease with maintenance therapy using bevacizumab and tamoxifen in a patient with metastatic breast cancer 42
An exceptional overall survival using bevacizumab beyond progression in a patient with Non-small cell lung cancer 41
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer 41
Thymostimulin in Association with Chemotherapy in Breast Cancer Patients with Bone Metastases 40
Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM) 39
null 39
Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate 33
The Percentage of Signet Ring Cells Is Inversely Related to Aggressive Behavior and Poor Prognosis in Mixed-Type Gastric Cancer 32
Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience. 31
Specific clonal expansion at disease progression (PD) in solid cancers pinpointed by cell free DNA analysis 29
Low-Dose Estramustine Phosphate and Concomitant Low-Dose Acetylsalicylic Acid in Heavily Pretreated Patients With Advanced Castration-Resistant Prostate Cancer. 25
Surgical management of advanced gastric cancer: An evolving issue 23
Totale 5.940
Categoria #
all - tutte 17.654
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.654


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019452 0 0 0 0 0 0 0 43 16 72 155 166
2019/20201.375 128 48 85 176 65 83 113 205 199 121 51 101
2020/20211.143 48 114 48 108 69 114 69 178 91 134 87 83
2021/2022727 57 63 51 45 31 39 32 33 35 72 97 172
2022/20231.008 57 70 141 108 86 205 41 83 106 51 32 28
2023/2024806 38 22 96 54 39 239 311 7 0 0 0 0
Totale 5.940